🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#STGI happy hour celebrating our fellows & the accomplishments within our group. K12 awards, Parker Institute for Cancer Immunotherapy & MSKSociety Grants, @W_Park_MD Steve Maron. Important manuscripts published. @sloan_kettering Neil H. Segal MD PhD Yelena Y. Janjigian MD Ghassan Abou-Alfa Eileen M O’Reilly

Great honor Ghassan Abou-Alfa @sloan_kettering to discuss new treatment for #HCC with Sebastian @SCOM Chile Watch “Nuevos tratamientos en hepatocarcinoma” on #Vimeo vimeo.com/359419105

The new and rapidly evolving era of ERBB@ targeting for Gallbladder Cancer! Well done Sebastian Genomic Characterization of <i>ERBB2</i>-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine ascopubs.org/doi/full/10.12…

Great experience to participate in this project under the guidance of Ghassan Abou-Alfa and Dr. Bob Li. We need more treatment alternatives in Gallbladder Cancer.

Consideramos graves las acusaciones del ministro #Mañalich. Es de suma importancia recalcar que somos una sociedad científica y no lucramos con nuestros pacientes. #SCOM #Oncología #SociedadChilenaDeOncologíaMédica

Carta al Director, publicada hoy en #LUN, elaborada por la Directiva de la Sociedad Chilena de #Oncología Médica (SCOM), a raíz de las declaraciones del ministro Mañalich ante la Comisión de Hacienda del Senado, el 25 de noviembre.

Terrific to see olaparib FDA approved today for gBRCA related pancreas cancer as maintenance therapy. Adds an option for subset of people MSKCC Center for Pancreatic Cancer Research NEJM Talia Golan and many others including AZ, Merck!

Excited for Feb 5 all star ⭐️ ⭐️⭐️⭐️⭐️⭐️ @sloan_kettering NYU Langone Health line up. Please register and participate in the expert discussion. OncLive SOSS OncLive.com Ghassan Abou-Alfa ILSON David Diane M. Simeone, MD Eileen M O’Reilly MSKCC Center for Pancreatic Cancer Research free registration & food onclive.com/meetings/soss

Busy week for hepatobiliary cancers: Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study thelancet.com/journals/lanon…

Ya gente!!! Ayúdenme con la difusión de este tremendo diplomado que empezaremos en dos semanitas... Hay un gran equipo docente y mucha dedicación detrás no se lo pierda! Nota: si no es médico/a y lo encuentra muy caro me escribe DM

Congratulations on superb continued work Universidad Católica Sebastian Juan Carlos Roa Santiago Sepulveda to better understand #gallbladdercancer. Memorial Sloan Kettering Cancer Center MSK Department of Medicine Ghassan Abou-Alfa and team, honored and delighted to continue this global collaboration with #Chile

Welcome back to Memorial Sloan Kettering Cancer Center and #NewYorkCity Sebastian . Yelena Y. Janjigian MD Ghassan Abou-Alfa and all other dear colleagues were delighted to see you!

Tremendous effort and work by my friend and colleague Sebastian in this collaborative work between Facultad Medicina UC and Memorial Sloan Kettering Cancer Center lead by Ghassan Abou-Alfa

El Dr. Felipe Quezada, se refiere al cáncer colorrectal oligometastásico, en la Sesión Manejo de enfermedad oligometastásica, en las #JornadasSCOM2022. #SCOM #Cáncer #Oncología #OncologíaMédica #CáncerColorrectal #Oligometástasis

Very grateful for the opportunity to participate in this wonderful conference organized by Dr. Bob Li, Asia Society NY and Memorial Sloan Kettering Cancer Center. Collaboration trough bold initiatives like this one is the way to move forward. #cure4cancer

Derek O'Reilly Eileen M O’Reilly MSKCC Center for Pancreatic Cancer Research Beyond her obvious massive clinical + scientific contributions to the field, it is her kindness and empathy that makes her an exemplary ambassador for our profession! #pancsm

Instantáneas de hoy en el cierre del diplomado de oncología básica Facultad Medicina UC. Muy buena energía, gente motivada, ideas para el futuro. Gracias a quienes confiaron para aprender con nosotros, y por supuesto al equipo docente / administrativo! Si quiere hacerlo el 2025, DM

📢 Join myself, Sebastian and Andreana N. Holowatyj at #ASCO25 for a deep dive into the evolving landscape of #CRC care. 🔬 Biomarker-driven tx in mCRC 🧬 Neoadjuvant strategies in localized disease 📈 The rise of early-onset CRC #crcsm #EOCRC #ASCO25